Brain scan-ss-563672869 Before study initiation, NSE levels were similar for both groups. On Day 3 of the study, the NSE levels were 7.95 ± 2.86 ng/mL for the memantine group and 12.33 ± 7.09 ng ...

Memantine is administered orally, and appears as a fine white-to-off-white powder that is soluble in water. Since 2002, it has been available as 5- and 10-mg tablets and as an oral solution for ...

Memantine is the first drug that targets a second neurotransmitter called glutamate. What that means — the mechanism is distinct. It has a general effect on cognition and behavior and function.

October 2, 2008 (Salt Lake City, Utah) — New trial data suggest that a large 28-mg, once-daily dose of memantine (Namenda, Axura, Forest Pharmaceuticals) in an extended-release formulation may ...

Chilukuri et al 1 have composed an excellent review of pharmacologic interventions for reduction of neurocognitive deficits following radiation to the brain. We strongly agree with the conclusions of ...

If you can target high risk patients in their late 50s or early 60s for preventative trials, it really wouldn't be before those patients reach their 80s that you could draw a long-term conclusion.

Among users of antidementia drugs, persons using memantine have the highest risk of pneumonia, new research shows. The use of rivastigmine patches is associated with an increased risk as well, say ...

In September 2009, IQWiG concluded that no benefit has been proven for memantine in the treatment of Alzheimer's disease. An assessment now presented of twp previously unpublished studies and new ...

The comparisons suggest that memantine might be considered a first-line treatment equal to behavioral therapy in the treatment process for these conditions, according to the study. Grant said the ...

According to IQVIA ®, U.S. annual sales for memantine/donepezil tablets, everolimus tablets and rifaximin tablets for the 12 months ended November 2024 were approximately $88 million, $114 ...

In particular, compared to no drug use, the combined use of Memantine and Donepezil significantly increased the probability of five-year survival by 0.05 (6.4%).